High Content Analysis Provides Mechanistic Insights on the Pathways of Toxicity Induced by Amine-Modified Polystyrene Nanoparticles

The fast-paced development of nanotechnology needs the support of effective safety testing. We have developed a screening platform measuring simultaneously several cellular parameters for exposure to various concentrations of nanoparticles (NPs). Cell lines representative of different organ cell types, including lung, endothelium, liver, kidney, macrophages, glia, and neuronal cells were exposed to 50 nm amine-modified polystyrene (PS-NH2) NPs previously reported to induce apoptosis and to 50 nm sulphonated and carboxyl-modified polystyrene NPs that were reported to be silent. All cell lines apart from Raw 264.7 executed apoptosis in response to PS-NH2 NPs, showing specific sequences of EC50 thresholds; lysosomal acidification was the most sensitive parameter. Loss of mitochondrial membrane potential and plasma membrane integrity measured by High Content Analysis resulted comparably sensitive to the equivalent OECD-recommended assays, allowing increased output. Analysis of the acidic compartments revealed good cerrelation between size/fluorescence intensity and dose of PS-NH2 NPs applied; moreover steatosis and phospholipidosis were observed, consistent with the lysosomal alterations revealed by Lysotracker green; similar responses were observed when comparing astrocytoma cells with primary astrocytes. We have established a platform providing mechanistic insights on the response to exposure to nanoparticles. Such platform holds great potential for in vitro screening of nanomaterials in highthroughput format.

[1]  H. Bouwmeester,et al.  Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. , 2012, ACS nano.

[2]  Iseult Lynch,et al.  Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. , 2011, Journal of the American Chemical Society.

[3]  Maria Alessandrelli,et al.  CLP application to nanomaterials: a specific aspect. , 2011, Annali dell'Istituto superiore di sanita.

[4]  K. Dawson,et al.  Time and space resolved uptake study of silica nanoparticles by human cells. , 2011, Molecular bioSystems.

[5]  C. Röcker,et al.  Endo- and exocytosis of zwitterionic quantum dot nanoparticles by live HeLa cells. , 2010, ACS nano.

[6]  Kenneth A Dawson,et al.  A new methodology for studying nanoparticle interactions in biological systems: dispersing titania in biocompatible media using chemical stabilisers. , 2011, Nanoscale.

[7]  O. Olopade,et al.  Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. , 1997, The cancer journal from Scientific American.

[8]  H. Düssmann,et al.  Calpains Are Downstream Effectors of bax-Dependent Excitotoxic Apoptosis , 2012, The Journal of Neuroscience.

[9]  Betty Y. S. Kim,et al.  Current concepts: Nanomedicine , 2010 .

[10]  Robert Rallo,et al.  Use of a high-throughput screening approach coupled with in vivo zebrafish embryo screening to develop hazard ranking for engineered nanomaterials. , 2011, ACS nano.

[11]  J. Lamerdin,et al.  Identifying off-target effects and hidden phenotypes of drugs in human cells , 2006, Nature chemical biology.

[12]  Jeremy C Simpson,et al.  Time resolved study of cell death mechanisms induced by amine-modified polystyrene nanoparticles. , 2013, Nanoscale.

[13]  Iseult Lynch,et al.  Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines. , 2011, Small.

[14]  Kenneth A Dawson,et al.  Low dose of amino-modified nanoparticles induces cell cycle arrest. , 2013, ACS nano.

[15]  Luca Costantino,et al.  Interaction of nanoparticles with immunocompetent cells: nanosafety considerations. , 2012, Nanomedicine.

[16]  Fengjuan Wang,et al.  The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[17]  P. Hoet,et al.  Nanoparticles – known and unknown health risks , 2004, Journal of nanobiotechnology.

[18]  K. Yeow,et al.  Cellular imaging in drug discovery , 2006, Nature Reviews Drug Discovery.

[19]  Lutz Mädler,et al.  Use of metal oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute pulmonary inflammation. , 2012, ACS nano.

[20]  Andrew Bullen,et al.  Microscopic imaging techniques for drug discovery , 2008, Nature Reviews Drug Discovery.

[21]  Katharina Landfester,et al.  Amino‐functionalized polystyrene nanoparticles activate the NLRP3 inflammasome in human macrophages , 2011, ACS nano.

[22]  P. Bernardi,et al.  High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening , 2006, Archives of Toxicology.

[23]  Bengt Fadeel,et al.  Interactions of engineered nanoparticles with organs protected by internal biological barriers. , 2013, Small.

[24]  Jörg Rademann,et al.  Lysosomal Pathology and Osteopetrosis upon Loss of H+-Driven Lysosomal Cl– Accumulation , 2010, Science.

[25]  D. Green,et al.  Apoptosis and cancer: the failure of controls on cell death and cell survival. , 1995, Critical reviews in oncology/hematology.

[26]  Albert A Koelmans,et al.  Potential scenarios for nanomaterial release and subsequent alteration in the environment , 2012, Environmental toxicology and chemistry.

[27]  Marco P Monopoli,et al.  Biomolecular coronas provide the biological identity of nanosized materials. , 2012, Nature nanotechnology.

[28]  Sara Linse,et al.  Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[29]  P. O'Brien,et al.  Evaluation of the cytotoxicity of organic dust components on THP1 monocytes‐derived macrophages using high content analysis , 2014, Environmental toxicology.

[30]  Marc Devocelle,et al.  High content analysis to determine cytotoxicity of the antimicrobial peptide, melittin and selected structural analogs , 2011, Peptides.

[31]  Petra Krystek,et al.  Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. , 2008, Biomaterials.

[32]  Sung-hoon Ahn,et al.  Nanotechnology and its impact on food and nutrition: a review. , 2012, Recent patents on food, nutrition & agriculture.

[33]  Monty Liong,et al.  Cationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathways. , 2008, ACS nano.

[34]  D. Green,et al.  Apoptosis and oncogenesis: give and take in the BCL-2 family. , 2011, Current opinion in genetics & development.

[35]  K. Dawson,et al.  RNAi-mediated inhibition of apoptosis fails to prevent cationic nanoparticle-induced cell death in cultured cells. , 2014, Nanomedicine.

[36]  Rachel A. Kudgus,et al.  Intrinsic Therapeutic Applications of Noble Metal Nanoparticles: Past, Present and Future , 2012 .

[37]  Lutz Mädler,et al.  High content screening in zebrafish speeds up hazard ranking of transition metal oxide nanoparticles. , 2011, ACS nano.

[38]  G. Melino,et al.  Regulation of the apoptosis–necrosis switch , 2004, Oncogene.

[39]  Tian Xia,et al.  Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. , 2013, ACS nano.

[40]  Julia Gorelik,et al.  Respiratory epithelial cytotoxicity and membrane damage (holes) caused by amine-modified nanoparticles , 2012, Nanotoxicology.

[41]  S. Korsmeyer,et al.  Molecular thanatopsis: a discourse on the BCL2 family and cell death. , 1996, Blood.

[42]  Hongcai Gao,et al.  Coating graphene paper with 2D-assembly of electrocatalytic nanoparticles: a modular approach toward high-performance flexible electrodes. , 2012, ACS nano.

[43]  Yuri Volkov,et al.  High-content screening as a universal tool for fingerprinting of cytotoxicity of nanoparticles. , 2008, ACS nano.

[44]  G. Kaloyanides Drug-phospholipid interactions: role in aminoglycoside nephrotoxicity. , 1992, Renal failure.

[45]  John A. Tallarico,et al.  Integrating high-content screening and ligand-target prediction to identify mechanism of action. , 2008, Nature chemical biology.

[46]  Zhong Lin Wang,et al.  Lead zirconate titanate nanowire textile nanogenerator for wearable energy-harvesting and self-powered devices. , 2012, ACS nano.

[47]  Iseult Lynch,et al.  What the cell "sees" in bionanoscience. , 2010, Journal of the American Chemical Society.

[48]  R. Ientile,et al.  Apoptosis and necrosis occurring in excitotoxic cell death in isolated chick embryo retina , 2001, Journal of neurochemistry.

[49]  Kenneth A. Dawson,et al.  Cationic nanoparticles induce caspase 3-, 7- and 9-mediated cytotoxicity in a human astrocytoma cell line , 2011, Nanotoxicology.

[50]  G. Nohynek,et al.  Nano-sized cosmetic formulations or solid nanoparticles in sunscreens: A risk to human health? , 2012, Archives of Toxicology.

[51]  R. Lüllmann-Rauch,et al.  Lipidosis induced by amphiphilic cationic drugs. , 1978, Biochemical pharmacology.

[52]  Howard I. Maibach,et al.  OECD GUIDELINES FOR THE TESTING OF CHEMICALS In Vitro Skin Corrosion: Transcutaneous Electrical Resistance Test Method , 2013 .

[53]  Kenneth A. Dawson,et al.  Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population. , 2011, Nature nanotechnology.

[54]  S. Krol,et al.  Functionalized gold nanoparticles: a detailed in vivo multimodal microscopic brain distribution study. , 2010, Nanoscale.

[55]  Jorge Boczkowski,et al.  What's new in nanotoxicology? Implications for public health from a brief review of the 2008 literature , 2010, Nanotoxicology.

[56]  R. Lüllmann-Rauch,et al.  Freeze-fracture studies of cytoplasmic inclusions occurring in experimental lipidosis as induced by amphiphilic cationic drugs. , 1979, Biochimica et biophysica acta.

[57]  John Calvin Reed Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. , 1995, Current opinion in oncology.